Literature DB >> 15076183

Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure.

Claudio Borghi1, Maddalena Veronesi, Stefano Bacchelli, Daniela Degli Esposti, Eugenio Cosentino, Effore Ambrosioni.   

Abstract

RATIONALE: Elevated serum cholesterol levels are common in patients with high blood pressure (BP) and could contribute to the progression of the hypertensive disease.
OBJECTIVE: To determine whether serum cholesterol levels affect the BP response to mental stress (MA) and the development of stable hypertension in young subjects with high normal BP.
METHODS: Seventy young (age < 45 years) high normal BP subjects with elevated (> 200 mg/dl, n = 49; HC) or normal (< or = 199 mg/dl, n = 21; NC) serum cholesterol levels, and 20 normotensive normocholesterolaemic (serum cholesterol < 199 mg/dl; C) subjects undergoing standardized mental challenge (mental arithmetic) were followed up for 15 years according to a prospective, longitudinal, cohort study design conducted in an ambulatory setting. The main outcome measure was the evaluation of the 15-year incidence of stable hypertension (diastolic BP > 95 mmHg).
RESULTS: After adjustment for age, resting BP, family history of high BP and body mass index at the study entry, high normal BP subjects with HC showed an enhanced BP reactivity to stress and a higher 15-year incidence of stable hypertension compared to high normal BP and NC subjects [relative risk (RR) = 2.1; 95% confidence interval (CI) = 1.7-5.5, P < 0.001] and controls (RR = 3.1; 95% CI = 1.4-5.3, P < 0.001). In a multivariate analysis of data the presence of high cholesterol levels was an independent predictor for the development of hypertension.
CONCLUSION: These data suggest that subjects with high normal BP and elevated serum cholesterol might have an exaggerated cardiovascular response to stress and have an increased risk for stable hypertension that can be detected at young age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076183     DOI: 10.1097/00004872-200402000-00009

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Combined effect of hyperuricemia and overweight/obesity on the prevalence of hypertension among US adults: result from the National Health and Nutrition Examination Survey.

Authors:  G-M Han; S Gonzalez; D DeVries
Journal:  J Hum Hypertens       Date:  2014-05-01       Impact factor: 3.012

2.  Relationship Between Lipid Profiles and Hypertension: A Cross-Sectional Study of 62,957 Chinese Adult Males.

Authors:  Siwei Chen; Wenke Cheng
Journal:  Front Public Health       Date:  2022-05-18

3.  Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the Strong Heart Study.

Authors:  Giovanni de Simone; Richard B Devereux; Marcello Chinali; Mary J Roman; Thomas K Welty; Elisa T Lee; Barbara V Howard
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844

4.  Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study.

Authors:  Marina De Marco; Giovanni de Simone; Mary J Roman; Marcello Chinali; Elisa T Lee; Marie Russell; Barbara V Howard; Richard B Devereux
Journal:  Hypertension       Date:  2009-08-31       Impact factor: 10.190

5.  Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population.

Authors:  Toshiaki Otsuka; Hirotaka Takada; Yasuhiro Nishiyama; Eitaro Kodani; Yoshiyuki Saiki; Katsuhito Kato; Tomoyuki Kawada
Journal:  J Am Heart Assoc       Date:  2016-03-25       Impact factor: 5.501

6.  Dyslipidemia and the Prevalence of Hypertension: A Cross-Sectional Study Based on Chinese Adults Without Type 2 Diabetes Mellitus.

Authors:  Wenke Cheng; Jingqi Zhuang; Siwei Chen
Journal:  Front Cardiovasc Med       Date:  2022-07-07

7.  The relationship between lipid risk score and new-onset hypertension in a prospective cohort study.

Authors:  Hankun Xie; Qian Zhuang; Jialing Mu; Junxiang Sun; Pengfei Wei; Xianghai Zhao; Yanchun Chen; Jiayi Dong; Changying Chen; Lai Wei; Yunjie Yin; Song Yang; Chong Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-28       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.